VRDN Latest Headlines

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN)

at www.tipranks.com (Wed, 4-Feb 7:51 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Demant (OtherWILLF), Viridian Therapeutics (VRDN) and Tenet Healthcare (THC)

at www.tipranks.com (Tue, 3-Feb 7:31 AM)

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Viridian Therapeutics (VRDN) and Enovis (ENOV)

at www.tipranks.com (Mon, 2-Feb 7:11 AM)

Viridian Grants 16,650 Inducement Options as Pipeline Progresses in Thyroid Eye Disease

Market Chameleon (Fri, 9-Jan 9:40 AM)

Viridian’s Veligrotug Advances with FDA Priority Review—Pivotal Data Shows Robust, Rapid Results for Thyroid Eye Disease

Market Chameleon (Mon, 22-Dec 11:17 AM)

Viridian Therapeutics Secures Nearly $900 Million, Eyes Profitability and Mid-2026 Product Launch

Market Chameleon (Thu, 6-Nov 10:37 AM)